Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-24

Clinical Trial Update: Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial [Phase 1, Phase 2]

View source ↗

Summary

A pilot feasibility trial exploring glutamatergic modulation to enhance motivation in cocaine use disorders; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Cocaine Use Disorders | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-04-24